Advertisement

Archives of Toxicology

, Volume 89, Issue 2, pp 193–199 | Cite as

Acetaminophen hepatotoxicity: an updated review

  • Elizabeth M. Lancaster
  • Jonathan R. Hiatt
  • Ali Zarrinpar
Review Article

Abstract

As the most common cause of acute liver failure (ALF) in the USA and UK, acetaminophen-induced hepatotoxicity remains a significant public health concern and common indication for emergent liver transplantation. This problem is largely attributable to acetaminophen combination products frequently prescribed by physicians and other healthcare professionals, with unintentional and chronic overdose accounting for over 50 % of cases of acetaminophen-related ALF. Treatment with N-acetylcysteine can effectively reduce progression to ALF if given early after an acute overdose; however, liver transplantation is the only routinely used life-saving therapy once ALF has developed. With the rapid course of acetaminophen-related ALF and limited supply of donor livers, early and accurate diagnosis of patients that will require transplantation for survival is crucial. Efforts in developing novel treatments for acetaminophen-induced ALF are directed toward bridging patients to recovery. These include auxiliary, artificial, and bioartificial support systems. This review outlines the most recent developments in diagnosis and management of acetaminophen-induced ALF.

Keywords

Acetaminophen Acute liver failure Drug toxicity Liver transplantation 

References

  1. Bateman DN, Carroll R, Pettie J et al (2014a) Effect of the UK’s revised paracetamol poisoning management guidelines on admissions, adverse reactions and costs of treatment. Br J Clin Pharmacol 78:610–618. doi: 10.1111/bcp.12362 PubMedCentralPubMedCrossRefGoogle Scholar
  2. Bateman DN, Dear JW, Carroll R et al (2014b) Impact of reducing the threshold for acetylcysteine treatment in acute paracetamol poisoning: the recent United Kingdom experience. Clin Toxicol 52:868–872. doi: 10.3109/15563650.2014.954125 CrossRefGoogle Scholar
  3. Bateman DN, Dear JW, Thanacoody HK et al (2014c) Reduction of adverse effects from intravenous acetylcysteine treatment for paracetamol poisoning: a randomised controlled trial. Lancet 383:697–704. doi: 10.1016/S0140-6736(13)62062-0 PubMedCrossRefGoogle Scholar
  4. Bernuau J, Goudeau A, Poynard T et al (1986) Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology 6:648–651PubMedCrossRefGoogle Scholar
  5. Blieden M, Paramore LC, Shah D, Ben-Joseph R (2014) A perspective on the epidemiology of acetaminophen exposure and toxicity in the United States. Expert Rev Clin Pharmacol 7:341–348. doi: 10.1586/17512433.2014.904744 PubMedCrossRefGoogle Scholar
  6. Bunchorntavakul C, Reddy KR (2013) Acetaminophen-related hepatotoxicity. Clin Liver Dis 17:587–607, viii. doi:  10.1016/j.cld.2013.07.005
  7. Cholongitas E, Theocharidou E, Vasianopoulou P et al (2012) Comparison of the sequential organ failure assessment score with the King’s College Hospital criteria and the model for end-stage liver disease score for the prognosis of acetaminophen-induced acute liver failure. Liver Transpl 18:405–412. doi: 10.1002/lt.23370 PubMedCrossRefGoogle Scholar
  8. Chun LJ, Tong MJ, Busuttil RW, Hiatt JR (2009) Acetaminophen hepatotoxicity and acute liver failure. J Clin Gastroenterol 43:342–349. doi: 10.1097/MCG.0b013e31818a3854 PubMedCrossRefGoogle Scholar
  9. Cooper SC, Aldridge RC, Shah T et al (2009) Outcomes of liver transplantation for paracetamol (acetaminophen)-induced hepatic failure. Liver Transpl 15:1351–1357. doi: 10.1002/lt.21799 PubMedCrossRefGoogle Scholar
  10. Court MH, Peter I, Hazarika S et al (2014) Candidate gene polymorphisms in patients with acetaminophen-induced acute liver failure. Drug Metab Dispos 42:28–32. doi: 10.1124/dmd.113.053546 PubMedCentralPubMedCrossRefGoogle Scholar
  11. Craig DG, Ford AC, Hayes PC, Simpson KJ (2010a) Systematic review: prognostic tests of paracetamol-induced acute liver failure. Aliment Pharmacol Ther 31:1064–1076. doi: 10.1111/j.1365-2036.2010.04279.x PubMedCrossRefGoogle Scholar
  12. Craig DG, Lee A, Hayes PC, Simpson KJ (2010b) Review article: the current management of acute liver failure. Aliment Pharmacol Ther 31:345–358. doi: 10.1111/j.1365-2036.2009.04175.x PubMedCrossRefGoogle Scholar
  13. Craig DG, Bates CM, Davidson JS et al (2012) Staggered overdose pattern and delay to hospital presentation are associated with adverse outcomes following paracetamol-induced hepatotoxicity. Br J Clin Pharmacol 73:285–294. doi: 10.1111/j.1365-2125.2011.04067.x PubMedCentralPubMedCrossRefGoogle Scholar
  14. Dhawan A, Puppi J, Hughes RD, Mitry RR (2010) Human hepatocyte transplantation: current experience and future challenges. Nat Rev Gastroenterol Hepatol 7:288–298. doi: 10.1038/nrgastro.2010.44 PubMedCrossRefGoogle Scholar
  15. Feng HL, Li Q, Wang L et al (2014) Indocyanine green clearance test combined with MELD score in predicting the short-term prognosis of patients with acute liver failure. Hepatobiliary Pancreat Dis Int 13:271–275PubMedCrossRefGoogle Scholar
  16. Fontana RJ, Ellerbe C, Durkalski VE et al (2014) Two-year outcomes in initial survivors with acute liver failure: results from a prospective, multicentre study. Liver Int. doi: 10.1111/liv.12632 Google Scholar
  17. Heard KJ (2008) Acetylcysteine for acetaminophen poisoning. N Engl J Med 359:285–292. doi: 10.1056/NEJMct0708278 PubMedCentralPubMedCrossRefGoogle Scholar
  18. Herrera MB, Fonsato V, Bruno S et al (2013) Human liver stem cells improve liver injury in a model of fulminant liver failure. Hepatology 57:311–319. doi: 10.1002/hep.25986 PubMedCrossRefGoogle Scholar
  19. Hwang JH, Kim YH, Noh JR et al (2014) The protective role of NAD(P)H:quinone oxidoreductase 1 on acetaminophen-induced liver injury is associated with prevention of adenosine triphosphate depletion and improvement of mitochondrial dysfunction. Arch Toxicol. doi: 10.1007/s00204-014-1340-5 PubMedGoogle Scholar
  20. Izumi S, Langley PG, Wendon J et al (1996) Coagulation factor V levels as a prognostic indicator in fulminant hepatic failure. Hepatology 23:1507–1511. doi: 10.1002/hep.510230630 PubMedCrossRefGoogle Scholar
  21. Jaeschke H, Williams CD, Ramachandran A, Bajt ML (2012) Acetaminophen hepatotoxicity and repair: the role of sterile inflammation and innate immunity. Liver Int 32:8–20. doi: 10.1111/j.1478-3231.2011.02501.x PubMedCentralPubMedCrossRefGoogle Scholar
  22. Karvellas CJ, Safinia N, Auzinger G et al (2010) Medical and psychiatric outcomes for patients transplanted for acetaminophen-induced acute liver failure: a case–control study. Liver Int 30:826–833. doi: 10.1111/j.1478-3231.2010.02243.x PubMedCrossRefGoogle Scholar
  23. Larson AM, Polson J, Fontana RJ et al (2005) Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology 42:1364–1372. doi: 10.1002/hep.20948 PubMedCrossRefGoogle Scholar
  24. Lee KK, Imaizumi N, Chamberland SR et al (2014) Targeting mitochondria with methylene blue protects mice against acetaminophen-induced liver injury. Hepatology. doi: 10.1002/hep.27385 Google Scholar
  25. Lodge JP, Dasgupta D, Prasad KR et al (2008) Emergency subtotal hepatectomy: a new concept for acetaminophen-induced acute liver failure: temporary hepatic support by auxiliary orthotopic liver transplantation enables long-term success. Ann Surg 247:238–249. doi: 10.1097/SLA.0b013e31816401ec PubMedCrossRefGoogle Scholar
  26. Michaut A, Moreau C, Robin MA, Fromenty B (2014) Acetaminophen-induced liver injury in obesity and nonalcoholic fatty liver disease. Liver Int 34:e171–e179. doi: 10.1111/liv.12514 PubMedCrossRefGoogle Scholar
  27. Michna E, Duh MS, Korves C, Dahl JL (2010) Removal of opioid/acetaminophen combination prescription pain medications: assessing the evidence for hepatotoxicity and consequences of removal of these medications. Pain Med 11:369–378. doi: 10.1111/j.1526-4637.2010.00811.x PubMedCrossRefGoogle Scholar
  28. Milesi-Halle A, Abdel-Rahman SM, Brown A et al (2011) Indocyanine green clearance varies as a function of N-acetylcysteine treatment in a murine model of acetaminophen toxicity. Chem Biol Interact 189:222–229. doi: 10.1016/j.cbi.2010.12.001 PubMedCentralPubMedCrossRefGoogle Scholar
  29. Mowry JB, Spyker DA, Cantilena LR Jr et al (2013) 2012 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 30th Annual Report. Clin Toxicol 51:949–1229. doi: 10.3109/15563650.2013.863906 CrossRefGoogle Scholar
  30. Myers RP, Shaheen AA, Li B, et al (2008) Impact of liver disease, alcohol abuse, and unintentional ingestions on the outcomes of acetaminophen overdose. Clin Gastroenterol Hepatol 6:918–25; quiz 837. doi:  10.1016/j.cgh.2008.02.053
  31. O’Grady J (2007) Modern management of acute liver failure. Clin Liver Dis 11:291–303. doi: 10.1016/j.cld.2007.04.011 PubMedCrossRefGoogle Scholar
  32. O’Grady J (2012) Liver transplantation for acute liver failure. Best Pract Res Clin Gastroenterol 26:27–33. doi: 10.1016/j.bpg.2012.01.012 PubMedCrossRefGoogle Scholar
  33. Possamai LA, McPhail MJ, Quaglia A et al (2013) Character and temporal evolution of apoptosis in acetaminophen-induced acute liver failure*. Crit Care Med 41:2543–2550. doi: 10.1097/CCM.0b013e31829791a2 PubMedCentralPubMedCrossRefGoogle Scholar
  34. Possamai LA, McPhail MJ, Khamri W et al (2014) The role of intestinal microbiota in murine models of acetaminophen-induced hepatotoxicity. Liver Int. doi: 10.1111/liv.12689 PubMedGoogle Scholar
  35. Rajput I, Prasad KR, Bellamy MC et al (2014) Subtotal hepatectomy and whole graft auxiliary transplantation for acetaminophen-associated acute liver failure. HPB 16:220–228. doi: 10.1111/hpb.12124 PubMedCrossRefGoogle Scholar
  36. Rumack BH, Peterson RC, Koch GG, Amara IA (1981) Acetaminophen overdose. 662 cases with evaluation of oral acetylcysteine treatment. Arch Intern Med 141:380–385PubMedCrossRefGoogle Scholar
  37. Rutherford A, King LY, Hynan LS et al (2012) Development of an accurate index for predicting outcomes of patients with acute liver failure. Gastroenterology 143:1237–1243. doi: 10.1053/j.gastro.2012.07.113 PubMedCentralPubMedCrossRefGoogle Scholar
  38. Schilling A, Corey R, Leonard M, Eghtesad B (2010) Acetaminophen: old drug, new warnings. Cleve Clin J Med 77:19–27. doi: 10.3949/ccjm.77a.09084 PubMedCrossRefGoogle Scholar
  39. Struecker B, Raschzok N, Sauer IM (2014) Liver support strategies: cutting-edge technologies. Nat Rev Gastroenterol Hepatol 11:166–176. doi: 10.1038/nrgastro.2013.204 PubMedCrossRefGoogle Scholar
  40. Suzuki A, Yuen N, Walsh J et al (2009) Co-medications that modulate liver injury and repair influence clinical outcome of acetaminophen-associated liver injury. Clin Gastroenterol Hepatol 7:882–888. doi: 10.1016/j.cgh.2009.03.034 PubMedCrossRefGoogle Scholar
  41. Woolbright BL, McGill MR, Staggs VS et al (2014) Glycodeoxycholic acid levels as prognostic biomarker in acetaminophen-induced acute liver failure patients. Toxicol Sci. doi: 10.1093/toxsci/kfu195 PubMedGoogle Scholar
  42. Zhao L, Pickering G (2011) Paracetamol metabolism and related genetic differences. Drug Metab Rev 43:41–52. doi: 10.3109/03602532.2010.527984 PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg (outside the USA) 2014

Authors and Affiliations

  • Elizabeth M. Lancaster
    • 1
  • Jonathan R. Hiatt
    • 2
  • Ali Zarrinpar
    • 3
  1. 1.UCLA David Geffen School of MedicineLos AngelesUSA
  2. 2.Department of SurgeryUCLA David Geffen School of MedicineLos AngelesUSA
  3. 3.Division of Liver and Pancreas Transplantation, Department of SurgeryUCLA David Geffen School of MedicineLos AngelesUSA

Personalised recommendations